FDA Clearance Tracker · P190021-S005
ReActiv8 Implantable Neurostimulation System
Last checked: Nov 20, 2026Latest source record: Aug 24, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Aug 24, 2023
Approved
Time to decision
140 days
Received Apr 6, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P190021-S005
- Device name
- ReActiv8 Implantable Neurostimulation System
- Applicant
- Mainstay Medical Limited
- Applicant location
- Swords, Co Dublin
- Received
- Apr 6, 2023
- Decided
- Aug 24, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P190021
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at 2159 India Street, San Diego, California 92101, for the manufacturing of the ReActiv8 Implantable Neurostimulation System.
Source documents
Other decisions for Mainstay Medical Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P190021 · Decided Jun 16, 2020 · 292 days after receipt
Device type: Stimulator, neuromuscular, lower back muscles, totally implanted for pain relief (QLK) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.